English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Actueel
- Semiconductor Laser Therapy Device Market to Grow at a CAGR of 692.8% Through 2032
According to a newly published market research report by 24LifeSciences, global semiconductor laser therapy device market was valued at USD 441.5 million in 2023 and is projected to reach USD 692.8 million by 2030, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period 2024–2030.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/14785/semiconductor-laser-therapy-device-marketSemiconductor Laser Therapy Device Market to Grow at a CAGR of 692.8% Through 2032 According to a newly published market research report by 24LifeSciences, global semiconductor laser therapy device market was valued at USD 441.5 million in 2023 and is projected to reach USD 692.8 million by 2030, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period 2024–2030. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/14785/semiconductor-laser-therapy-device-market0 Reacties 0 aandelen 53 Views - Global SDS Poly Acrylamide Gel Electrophoresis Market to Reach USD 1.1 Billion by 2032
According to a newly published market research report by 24LifeSciences, global SDS Poly Acrylamide Gel Electrophoresis market was valued at USD 815 million in 2024 and is projected to reach USD 1,127 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period 2025-2031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15923/sds-poly-acrylamide-gel-electrophoresis-marketGlobal SDS Poly Acrylamide Gel Electrophoresis Market to Reach USD 1.1 Billion by 2032 According to a newly published market research report by 24LifeSciences, global SDS Poly Acrylamide Gel Electrophoresis market was valued at USD 815 million in 2024 and is projected to reach USD 1,127 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period 2025-2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15923/sds-poly-acrylamide-gel-electrophoresis-market0 Reacties 0 aandelen 209 Views - Obturation System Market to Reach USD 1.7 Billion by 2032
According to a newly published market research report by 24LifeSciences, global obturation system market was valued at USD 1.2 billion in 2024 and is projected to reach USD 1.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025-2032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13189/obturation-system-marketObturation System Market to Reach USD 1.7 Billion by 2032 According to a newly published market research report by 24LifeSciences, global obturation system market was valued at USD 1.2 billion in 2024 and is projected to reach USD 1.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025-2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13189/obturation-system-market0 Reacties 0 aandelen 223 Views - MRI (Magnetic Resonance Imaging System) Market to Reach USD 7.48 Billion by 2032
According to a newly published market research report by 24LifeSciences, the global MRI (Magnetic Resonance Imaging System) Market was valued at USD 5.84 billion in 2024 and is projected to reach USD 7.48 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2025–2031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7686/mri-magnetic-resance-imaging-system-marketMRI (Magnetic Resonance Imaging System) Market to Reach USD 7.48 Billion by 2032 According to a newly published market research report by 24LifeSciences, the global MRI (Magnetic Resonance Imaging System) Market was valued at USD 5.84 billion in 2024 and is projected to reach USD 7.48 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7686/mri-magnetic-resance-imaging-system-market0 Reacties 0 aandelen 221 Views - Global Proton Pump Inhibitors Market to Reach USD 8.2 Billion by 2031
According to a newly published market research report by 24LifeSciences, global Proton Pump Inhibitors market was valued at USD 10,440 million in 2024 and is projected to reach USD 8,202 million by 2031, declining at a compound annual growth rate (CAGR) of -3.5% during the forecast period 20252031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3702/proton-pump-inhibitors-marketGlobal Proton Pump Inhibitors Market to Reach USD 8.2 Billion by 2031 According to a newly published market research report by 24LifeSciences, global Proton Pump Inhibitors market was valued at USD 10,440 million in 2024 and is projected to reach USD 8,202 million by 2031, declining at a compound annual growth rate (CAGR) of -3.5% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3702/proton-pump-inhibitors-market0 Reacties 0 aandelen 266 Views - Global Piracetam for Injection Market to Reach USD 315 Million by 2032
According to a newly published market research report by 24LifeSciences, global Piracetam for Injection market was valued at USD 215 million in 2024 and is projected to reach USD 315 million by 2032, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2025–2032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10530/piracetam-for-injection-marketGlobal Piracetam for Injection Market to Reach USD 315 Million by 2032 According to a newly published market research report by 24LifeSciences, global Piracetam for Injection market was valued at USD 215 million in 2024 and is projected to reach USD 315 million by 2032, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10530/piracetam-for-injection-market0 Reacties 0 aandelen 222 Views - Anticholinergics and Antispasmodics Market Growth, Forecast & Key Players
According to a newly published market research report by 24LifeSciences, global anticholinergics and antispasmodics market was valued at USD 1.2 billion in 2024 and is projected to reach USD 1.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13986/anticholinergics-and-antispasmodics-marketAnticholinergics and Antispasmodics Market Growth, Forecast & Key Players According to a newly published market research report by 24LifeSciences, global anticholinergics and antispasmodics market was valued at USD 1.2 billion in 2024 and is projected to reach USD 1.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13986/anticholinergics-and-antispasmodics-market0 Reacties 0 aandelen 260 Views - Medical Grade Touchscreen Monitor Market 7.0% CAGR: Top Companies in 2026
According to a newly published market research report by 24LifeSciences, global medical grade touchscreen monitor market was valued at USD 1153 million in 2024 and is projected to reach USD 1812 million by 2031, growing at a compound annual growth rate (CAGR) of 7.0% during the forecast period.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4935/medical-grade-touchscreen-monitor-marketMedical Grade Touchscreen Monitor Market 7.0% CAGR: Top Companies in 2026 According to a newly published market research report by 24LifeSciences, global medical grade touchscreen monitor market was valued at USD 1153 million in 2024 and is projected to reach USD 1812 million by 2031, growing at a compound annual growth rate (CAGR) of 7.0% during the forecast period. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4935/medical-grade-touchscreen-monitor-market0 Reacties 0 aandelen 262 Views - Cardiac Bio-Implant Devices Market Size, Share & Revenue Outlook 2032
According to a newly published market research report by 24LifeSciences, global cardiac bio-implant devices market was valued at USD 15.6 billion in 2024 and is projected to reach USD 28.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period 20252031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15948/cardiac-bio-implant-devices-marketCardiac Bio-Implant Devices Market Size, Share & Revenue Outlook 2032 According to a newly published market research report by 24LifeSciences, global cardiac bio-implant devices market was valued at USD 15.6 billion in 2024 and is projected to reach USD 28.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15948/cardiac-bio-implant-devices-market0 Reacties 0 aandelen 406 Views - Omalizumab Monoclonal Antibody Biosimilars Market Growth, Forecast & Key Players
According to a newly published market research report by 24LifeSciences, global omalizumab monoclonal antibody biosimilars market was valued at USD 318 million in 2024 and is projected to reach USD 582 million by 2032, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13928/omalizumab-monoclonal-antibody-biosimilars-marketOmalizumab Monoclonal Antibody Biosimilars Market Growth, Forecast & Key Players According to a newly published market research report by 24LifeSciences, global omalizumab monoclonal antibody biosimilars market was valued at USD 318 million in 2024 and is projected to reach USD 582 million by 2032, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13928/omalizumab-monoclonal-antibody-biosimilars-market0 Reacties 0 aandelen 397 Views
Meer blogs